ELDN ELEDON PHARMACEUTICALS INC
Health Care · Russell 2000
Next earnings: Fri 13 Nov 2026 · estimated
What 9 analyst firms say about ELEDON PHARMACEUTICALS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 3 reports on ELDN from 3 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Cantor Fitzgerald | Pete Stavropoulos | Buy | 23 Mar 2026 | — |
| Craig-Hallum | Albert Lowe | Buy | 16 Mar 2026 | 12.00 USD |
| Guggenheim | Vamil Divan | Buy | 14 Aug 2026 | 8.00 USD |
| Leerink Partners | Thomas J Smith | Buy | 22 Jun 2026 | 7.00 USD |
| Lifesci Capital | Rami Katkhuda | Buy | 22 Jun 2026 | 8.00 USD |
| Noble Capital Markets | Robert Leboyer | Buy | 4 Sep 2026 | 10.00 USD |
| Rodman & Renshaw | Seema Sheoran | Buy | 21 Jul 2026 | 12.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:25 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.